Vita 34 AG
XETRA:V3V
Vita 34 AG
Cash from Operating Activities
Vita 34 AG
Cash from Operating Activities Peer Comparison
Competitive Cash from Operating Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Operating Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Vita 34 AG
XETRA:V3V
|
Cash from Operating Activities
€3.6m
|
CAGR 3-Years
-10%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
7%
|
|
F
|
Fresenius Medical Care AG & Co KGaA
XETRA:FME
|
Cash from Operating Activities
€2.6B
|
CAGR 3-Years
-15%
|
CAGR 5-Years
5%
|
CAGR 10-Years
6%
|
F
|
Fresenius SE & Co KGaA
XETRA:FRE
|
Cash from Operating Activities
€4.4B
|
CAGR 3-Years
-12%
|
CAGR 5-Years
3%
|
CAGR 10-Years
7%
|
E
|
Euroeyes International Eye Clinic Ltd
HKEX:1846
|
Cash from Operating Activities
HK$208.8m
|
CAGR 3-Years
39%
|
CAGR 5-Years
8%
|
CAGR 10-Years
N/A
|
Synlab AG
XETRA:SYAB
|
Cash from Operating Activities
€363.1m
|
CAGR 3-Years
-11%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Vita 34 AG's Cash from Operating Activities?
Cash from Operating Activities
3.6m
EUR
Based on the financial report for Sep 30, 2023, Vita 34 AG's Cash from Operating Activities amounts to 3.6m EUR.
What is Vita 34 AG's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 10Y
7%
The average annual Cash from Operating Activities growth rates for Vita 34 AG have been -10% over the past three years , -4% over the past five years , and 7% over the past ten years .